| Product |
CAS |
Application |
StructureImage |
| Erythromycin B |
527-75-3 |
Erythromycin impurity |
|
|
| Erythromycin C |
N/A |
Erythromycin impurity |
|
|
| Erythromycin A Enol Ether |
33396-29-1 |
Erythromycin impurity reference standards |
|
|
| Dolasetron Mesylate |
115956-13-3 |
Dolasetron Mesylate reference standards |
|
|
| Dolasetron Mesylate Related Compound A |
N/A |
Dolasetron Mesylate reference standards |
|
|
| Rocuronium Bromide |
119302-91-9 |
Rocuronium Bromide reference standards |
|
|
| Rocuronium for peak identification |
N/A |
Rocuronium for peak identification |
|
|
| Ambroxol Hydrochloride Imp. A |
N/A |
Ambroxol Hydrochloride Imp reference standards |
|
|
| Ambroxol Hydrochloride Imp. C |
N/A |
Ambroxol Hydrochloride Imp reference standards |
|
|
| Ambroxol Hydrochloride Imp. B |
N/A |
Ambroxol Hydrochloride Imp reference standards |
|
|
| Ambroxol Hydrochloride Imp. D |
N/A |
Ambroxol Hydrochloride Imp reference standards |
|
|
| Ambroxol Hydrochloride Imp. E |
N/A |
Ambroxol Hydrochloride Imp |
|
|
| Moxifloxacin intermediate. |
112811-72-0 |
Moxifloxacin reference standards |
|
|
|
